CAS: 1038915-60-4 - Niraparib
Formula:C19H20N4O
InChI:InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1
InChI key:InChIKey=PCHKPVIQAHNQLW-CQSZACIVSA-N
SMILES:O=C(N)C1=CC=CC2=CN(N=C21)C3=CC=C(C=C3)C4CNCCC4
- Synonyms:
- (S)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide
- 2-[4-(3S)-3-Piperidinylphenyl]-2H-indazole-7-carboxamide
- 2-[4-[(3S)-Piperidin-3-yl]phenyl]indazole-7-carboxamide
- 2H-Indazole-7-carboxamide 2-[4-(3S)-3-piperidinylphenyl]-
2-[4-(3S)-3-Piperidinylphenyl]-2H-indazole-7-carboxamide
CAS:1038915-60-4
Formula:
C19H20N4O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
320.3883
Ref: IN-DA0038ZU
1g | 171.00 € | ||
5g | 479.00 € | ||
10mg | 40.00 € | ||
25mg | 46.00 € | ||
50mg | 68.00 € | ||
100mg | 79.00 € | ||
250mg | 121.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-N-116003
1mg | 830.00 € | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-N-116001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Niraparib
CAS:1038915-60-4
Niraparib (MK-4827) inhibits PARP1/PARP2 (IC50: 3.8/2.1 nM), effective on BRCA mutant cancers, 330x less effective …
Formula:
C19H20N4O
Purity:
98% - 99.91%
Color and Shape:
Solid
Molecular weight:
320.39
Ref: TM-T3231
5mg | 59.00 € | ||
10mg | 86.00 € | ||
25mg | 111.00 € | ||
50mg | 142.00 € | ||
100mg | 213.00 € | ||
200mg | 314.00 € | ||
500mg | 543.00 € | ||
1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
(S)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide
CAS:1038915-60-4
Purity:
95.0%
Molecular weight:
320.39599609375
Ref: 10-F227536
1g | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
Niraparib
Controlled ProductCAS:1038915-60-4
Applications Niraparib is a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant …
Formula:
C19H20N4O
Color and Shape:
Light Yellow
Molecular weight:
320.39
Ref: TR-N481400
5mg | 940.00 € | ||
25mg | 1,304.00 € | ||
2500µg | 697.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
Niraparib-D5 Major, >90%
Controlled ProductCAS:1038915-60-4
Formula:
C19D5H15N4O
Purity:
>90%
Color and Shape:
Neat
Molecular weight:
325.419
Ref: TR-N481406
1mg | 1,293.00 € | ||
500µg | 746.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
MK 4827
CAS:1038915-60-4
Inhibitor of PARP1 and PARP2 enzymes
Formula:
C19H20N4O
Purity:
Min. 96 Area-%
Color and Shape:
White Powder
Molecular weight:
320.39 g/mol
Ref: 3D-FP35532
5mg | 136.00 € | ||
10mg | 189.00 € | ||
25mg | 213.00 € | ||
50mg | 360.00 € | ||
100mg | 498.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024